Early detection and prevention of cancers in various therapeutic areas. Discussion

H. Akaza, T. Tsuruo, T. Tsukamoto, S. Noguchi, H. Moriwaki, S. Isonishi, N. Masuda, S. Hinotsu, A. F. Nash, M. von Euler, J. Wildin, D. Stribling

Research output: Contribution to journalArticle

Abstract

As illustrated by prostate cancer screening provides an opportunity for early intervention and treatment. However the screening test needs to detect patients with cancer with a low rate of false positives and at a stage which can be treated. Recently the concept of treating patients at high risk of developing breast cancer or suffering a recurrence has been highlighted by the western studies with Nolvadex (tamoxifen). Thus roundtable discussion (held in Tokyo) discussed the different strategies in Japan compared to US & Europe for screening & early intervention/prevention of cancer for breast, prostate, bladder, liver, lung, gynaecological & GI cancers. The range of strategies for cancer screening, how it is funded, whether it is appropriately targeted and whether there is any evidence for a beneficial effect on morbidity or mortality & future prospects for improved sensitivity through new methodology or markers were discussed. Although the relative rates of cancer vary between Japan & the West, the same factors seem to influence cancer development & the data on intervention were seen to be valid. The changing patterns of cancer in Japan suggest a clear opportunity for reducing, the incidence of cancer through lifestyle modification. For some cancers, e.g. cervical & bladder where there is a clear link between abnormal cytology & development cancer true prevention is already practiced. In other cases, preventive treatment is limited by the efficacy of available therapies. As far as drug treatment is concerned, funding of healthcare in Japan does not recognise the concept of prevention although there is, in practice, no barrier to the use of interventions where there is a clear link between biochemical/histological markers & development of cancer.

Original languageEnglish
Pages (from-to)1585-1597
Number of pages13
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume26
Issue number11
Publication statusPublished - Oct 1999
Externally publishedYes

Fingerprint

Early Detection of Cancer
Neoplasms
Japan
Tamoxifen
Therapeutics
Prostatic Neoplasms
Urinary Bladder
Breast Neoplasms
Tokyo
Uterine Cervical Neoplasms
Cell Biology
Life Style
Biomarkers
Morbidity
Delivery of Health Care
Recurrence
Lung
Mortality
Liver
Incidence

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology

Cite this

Akaza, H., Tsuruo, T., Tsukamoto, T., Noguchi, S., Moriwaki, H., Isonishi, S., ... Stribling, D. (1999). Early detection and prevention of cancers in various therapeutic areas. Discussion. Gan to kagaku ryoho. Cancer & chemotherapy, 26(11), 1585-1597.

Early detection and prevention of cancers in various therapeutic areas. Discussion. / Akaza, H.; Tsuruo, T.; Tsukamoto, T.; Noguchi, S.; Moriwaki, H.; Isonishi, S.; Masuda, N.; Hinotsu, S.; Nash, A. F.; von Euler, M.; Wildin, J.; Stribling, D.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 26, No. 11, 10.1999, p. 1585-1597.

Research output: Contribution to journalArticle

Akaza, H, Tsuruo, T, Tsukamoto, T, Noguchi, S, Moriwaki, H, Isonishi, S, Masuda, N, Hinotsu, S, Nash, AF, von Euler, M, Wildin, J & Stribling, D 1999, 'Early detection and prevention of cancers in various therapeutic areas. Discussion', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 26, no. 11, pp. 1585-1597.
Akaza H, Tsuruo T, Tsukamoto T, Noguchi S, Moriwaki H, Isonishi S et al. Early detection and prevention of cancers in various therapeutic areas. Discussion. Gan to kagaku ryoho. Cancer & chemotherapy. 1999 Oct;26(11):1585-1597.
Akaza, H. ; Tsuruo, T. ; Tsukamoto, T. ; Noguchi, S. ; Moriwaki, H. ; Isonishi, S. ; Masuda, N. ; Hinotsu, S. ; Nash, A. F. ; von Euler, M. ; Wildin, J. ; Stribling, D. / Early detection and prevention of cancers in various therapeutic areas. Discussion. In: Gan to kagaku ryoho. Cancer & chemotherapy. 1999 ; Vol. 26, No. 11. pp. 1585-1597.
@article{eb6b7bf2858c49a8878f4dbf616c52c2,
title = "Early detection and prevention of cancers in various therapeutic areas. Discussion",
abstract = "As illustrated by prostate cancer screening provides an opportunity for early intervention and treatment. However the screening test needs to detect patients with cancer with a low rate of false positives and at a stage which can be treated. Recently the concept of treating patients at high risk of developing breast cancer or suffering a recurrence has been highlighted by the western studies with Nolvadex (tamoxifen). Thus roundtable discussion (held in Tokyo) discussed the different strategies in Japan compared to US & Europe for screening & early intervention/prevention of cancer for breast, prostate, bladder, liver, lung, gynaecological & GI cancers. The range of strategies for cancer screening, how it is funded, whether it is appropriately targeted and whether there is any evidence for a beneficial effect on morbidity or mortality & future prospects for improved sensitivity through new methodology or markers were discussed. Although the relative rates of cancer vary between Japan & the West, the same factors seem to influence cancer development & the data on intervention were seen to be valid. The changing patterns of cancer in Japan suggest a clear opportunity for reducing, the incidence of cancer through lifestyle modification. For some cancers, e.g. cervical & bladder where there is a clear link between abnormal cytology & development cancer true prevention is already practiced. In other cases, preventive treatment is limited by the efficacy of available therapies. As far as drug treatment is concerned, funding of healthcare in Japan does not recognise the concept of prevention although there is, in practice, no barrier to the use of interventions where there is a clear link between biochemical/histological markers & development of cancer.",
author = "H. Akaza and T. Tsuruo and T. Tsukamoto and S. Noguchi and H. Moriwaki and S. Isonishi and N. Masuda and S. Hinotsu and Nash, {A. F.} and {von Euler}, M. and J. Wildin and D. Stribling",
year = "1999",
month = "10",
language = "English",
volume = "26",
pages = "1585--1597",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "11",

}

TY - JOUR

T1 - Early detection and prevention of cancers in various therapeutic areas. Discussion

AU - Akaza, H.

AU - Tsuruo, T.

AU - Tsukamoto, T.

AU - Noguchi, S.

AU - Moriwaki, H.

AU - Isonishi, S.

AU - Masuda, N.

AU - Hinotsu, S.

AU - Nash, A. F.

AU - von Euler, M.

AU - Wildin, J.

AU - Stribling, D.

PY - 1999/10

Y1 - 1999/10

N2 - As illustrated by prostate cancer screening provides an opportunity for early intervention and treatment. However the screening test needs to detect patients with cancer with a low rate of false positives and at a stage which can be treated. Recently the concept of treating patients at high risk of developing breast cancer or suffering a recurrence has been highlighted by the western studies with Nolvadex (tamoxifen). Thus roundtable discussion (held in Tokyo) discussed the different strategies in Japan compared to US & Europe for screening & early intervention/prevention of cancer for breast, prostate, bladder, liver, lung, gynaecological & GI cancers. The range of strategies for cancer screening, how it is funded, whether it is appropriately targeted and whether there is any evidence for a beneficial effect on morbidity or mortality & future prospects for improved sensitivity through new methodology or markers were discussed. Although the relative rates of cancer vary between Japan & the West, the same factors seem to influence cancer development & the data on intervention were seen to be valid. The changing patterns of cancer in Japan suggest a clear opportunity for reducing, the incidence of cancer through lifestyle modification. For some cancers, e.g. cervical & bladder where there is a clear link between abnormal cytology & development cancer true prevention is already practiced. In other cases, preventive treatment is limited by the efficacy of available therapies. As far as drug treatment is concerned, funding of healthcare in Japan does not recognise the concept of prevention although there is, in practice, no barrier to the use of interventions where there is a clear link between biochemical/histological markers & development of cancer.

AB - As illustrated by prostate cancer screening provides an opportunity for early intervention and treatment. However the screening test needs to detect patients with cancer with a low rate of false positives and at a stage which can be treated. Recently the concept of treating patients at high risk of developing breast cancer or suffering a recurrence has been highlighted by the western studies with Nolvadex (tamoxifen). Thus roundtable discussion (held in Tokyo) discussed the different strategies in Japan compared to US & Europe for screening & early intervention/prevention of cancer for breast, prostate, bladder, liver, lung, gynaecological & GI cancers. The range of strategies for cancer screening, how it is funded, whether it is appropriately targeted and whether there is any evidence for a beneficial effect on morbidity or mortality & future prospects for improved sensitivity through new methodology or markers were discussed. Although the relative rates of cancer vary between Japan & the West, the same factors seem to influence cancer development & the data on intervention were seen to be valid. The changing patterns of cancer in Japan suggest a clear opportunity for reducing, the incidence of cancer through lifestyle modification. For some cancers, e.g. cervical & bladder where there is a clear link between abnormal cytology & development cancer true prevention is already practiced. In other cases, preventive treatment is limited by the efficacy of available therapies. As far as drug treatment is concerned, funding of healthcare in Japan does not recognise the concept of prevention although there is, in practice, no barrier to the use of interventions where there is a clear link between biochemical/histological markers & development of cancer.

UR - http://www.scopus.com/inward/record.url?scp=0033210310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033210310&partnerID=8YFLogxK

M3 - Article

C2 - 10553416

AN - SCOPUS:0033210310

VL - 26

SP - 1585

EP - 1597

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 11

ER -